AngioDynamics CEO James Clemmer's 2019 pay rises 9% to $3.0M
AngioDynamics reports 2019 executive compensation
By ExecPay News
Published: September 5, 2019
AngioDynamics reported fiscal year 2019 executive compensation information on September 5, 2019.
In 2019, five executives at AngioDynamics received on average a compensation package of $1.4M, a 17% increase compared to previous year.
James C. Clemmer, Chief Executive Officer, received $3M in total, which increased by 9% compared to 2018. 39.92% of Clemmer's compensation, or $1.2M, was in stock awards. Clemmer also received $714K in non-equity incentive plan, $365.2K in option awards, $686.6K in salary, as well as $37.5K in other compensation.
For fiscal year 2019, the median employee pay was $45,490 at AngioDynamics. Therefore, the ratio of James C. Clemmer's pay to the median employee pay was 66 to one.
Michael C. Greiner, Chief Financial Officer, received a compensation package of $1.4M, which increased by 30% compared to previous year. 35.36% of the compensation package, or $479.3K, was in stock awards.
David D. Helsel, SVP, Global Operations and R&D, earned $958.3K in 2019, a 16% increase compared to previous year.
Robert A. Simpson, SVP and GM, Peripheral Vascular, received $950.9K in 2019, which increases by 16% compared to 2018.
Stephen A. Trowbridge, General Counsel, earned $941.4K in 2019, a 31% increase compared to previous year.
AngioDynamics' fiscal year ends on May 31.